Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Impact of mutation status on efficacy outcomes in TOPAZ-1: A phase III study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in advanced biliary tract cancer (BTC) | ANNALS OF ONCOLOGY |